{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:53:10Z","timestamp":1790095990568,"version":"4.0.1"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2017,6,12]],"date-time":"2017-06-12T00:00:00Z","timestamp":1497225600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"BioMarin Europe Ltd (UK)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1007\/s00415-017-8541-9","type":"journal-article","created":{"date-parts":[[2017,6,12]],"date-time":"2017-06-12T11:54:19Z","timestamp":1497268459000},"page":"1854-1863","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":72,"title":["Lambert\u2013Eaton myasthenic syndrome (LEMS): a rare autoimmune presynaptic disorder often associated with cancer"],"prefix":"10.1007","volume":"264","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2757-8131","authenticated-orcid":false,"given":"Benedikt","family":"Schoser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Eymard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe","family":"Datt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato","family":"Mantegazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,6,12]]},"reference":[{"key":"8541_CR1","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1001\/jama.1957.02970480021005","volume":"163","author":"LM Eaton","year":"1957","unstructured":"Eaton LM, Lambert EH (1957) Electromyography and electric stimulation of nerves in diseases of motor unit; observations on myasthenic syndrome associated with malignant tumors. J Am Med Assoc 163:1117\u20131124","journal-title":"J Am Med Assoc"},{"key":"8541_CR2","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/S1474-4422(11)70245-9","volume":"10","author":"MJ Titulaer","year":"2011","unstructured":"Titulaer MJ, Lang B, Verschuuren JJ (2011) Lambert\u2013Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies. Lancet Neurol 10:1098\u20131107","journal-title":"Lancet Neurol"},{"key":"8541_CR3","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1749-6632.1971.tb30750.x","volume":"183","author":"EH Lambert","year":"1971","unstructured":"Lambert EH, Elmqvist D (1971) Quantal components of end-plate potentials in the myasthenic syndrome. Ann N Y Acad Sci 183:183\u2013199","journal-title":"Ann N Y Acad Sci"},{"key":"8541_CR4","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0303-8467(02)00054-9","volume":"104","author":"PW Wirtz","year":"2002","unstructured":"Wirtz PW, Smallegange TM, Wintzen AR, Verschuuren JJ (2002) Differences in clinical features between the Lambert\u2013Eaton myasthenic syndrome with and without cancer: an analysis of 227 published cases. Clin Neurol Neurosurg 104:359\u2013363","journal-title":"Clin Neurol Neurosurg"},{"key":"8541_CR5","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3111\/13696998.2012.660897","volume":"15","author":"L Harms","year":"2012","unstructured":"Harms L, Sieb JP, Williams AE et al (2012) Long-term disease history, clinical symptoms, health status, and healthcare utilization in patients suffering from Lambert Eaton myasthenic syndrome: results of a patient interview survey in Germany. J Med Econ 15:521\u2013530","journal-title":"J Med Econ"},{"key":"8541_CR6","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1185\/03007991003745209","volume":"26","author":"A Quartel","year":"2010","unstructured":"Quartel A, Turbeville S, Lousbury D (2010) Current therapy for Lambert\u2013Eaton myasthenic syndrome: development of 3,4-diaminopyridine phosphate salt as first-line symptomatic treatment. Curr Med Res Opin 26:1363\u20131375","journal-title":"Curr Med Res Opin"},{"key":"8541_CR7","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1136\/jnnp.70.2.212","volume":"70","author":"P Maddison","year":"2001","unstructured":"Maddison P, Lang B, Mills K, Newsom-Davis J (2001) Long term outcome in Lambert\u2013Eaton myasthenic syndrome without lung cancer. J Neurol Neurosurg Psychiatry 70:212\u2013217","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8541_CR8","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s10072-014-1637-4","volume":"35","author":"A Evoli","year":"2014","unstructured":"Evoli A, Liguori R, Romani A et al (2014) Italian recommendations for Lambert\u2013Eaton myasthenic syndrome (LEMS) management. Neurol Sci 35:515\u2013520","journal-title":"Neurol Sci"},{"key":"8541_CR9","unstructured":"Orphanet (2013) Lambert\u2013Eaton myasthenic syndrome. http:\/\/www.orpha.net\/consor\/cgi-bin\/OC_Exp.php?Lng=EN&Expert=43393 . Accessed 10 Feb 2017"},{"key":"8541_CR10","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1007\/s00415-003-1063-7","volume":"250","author":"PW Wirtz","year":"2003","unstructured":"Wirtz PW, Nijnuis MG, Sotodeh M et al (2003) The epidemiology of myasthenia gravis, Lambert\u2013Eaton myasthenic syndrome and their associated tumors in the northern part of the province of South Holland. J Neurol 250:698\u2013701","journal-title":"J Neurol"},{"key":"8541_CR11","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1212\/01.WNL.0000130254.27019.14","volume":"63","author":"PW Wirtz","year":"2004","unstructured":"Wirtz PW, van Dijk JG, van Doorn PA et al (2004) The epidemiology of the Lambert\u2013Eaton myasthenic syndrome in the Netherlands. Neurology 63:397\u2013398","journal-title":"Neurology"},{"key":"8541_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/mus.25520","author":"DC Abenroth","year":"2016","unstructured":"Abenroth DC, Smith AG, Greenlee JE, Austin SD, Clardy SL (2016) Lambert\u2013Eaton myasthenic syndrome (LEMS): epidemiology and therapeutic response in the national Veterans Affairs (VA) population. Muscle Nerve doi: 10.1002\/mus.25520","journal-title":"Muscle Nerve"},{"issue":"Pt 3","key":"8541_CR13","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/brain\/111.3.577","volume":"111","author":"JH O\u2019Neill","year":"1988","unstructured":"O\u2019Neill JH, Murray NM, Newsom-Davis J (1988) The Lambert\u2013Eaton myasthenic syndrome. A review of 50 cases. Brain 111(Pt 3):577\u2013596","journal-title":"Brain"},{"key":"8541_CR14","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1200\/JCO.2010.32.0440","volume":"29","author":"MJ Titulaer","year":"2011","unstructured":"Titulaer MJ, Maddison P, Sont JK et al (2011) Clinical Dutch-English Lambert\u2013Eaton myasthenic syndrome (LEMS) tumor association prediction score accurately predicts small-cell lung cancer in the LEMS. J Clin Oncol 29:902\u2013908","journal-title":"J Clin Oncol"},{"key":"8541_CR15","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/0140-6736(90)90248-4","volume":"335","author":"E Sher","year":"1990","unstructured":"Sher E, Comola M, Nemni R, Canal N, Clementi F (1990) Calcium channel autoantibody and non-small-cell lung cancer in patients with Lambert\u2013Eaton syndrome. Lancet 335:413","journal-title":"Lancet"},{"key":"8541_CR16","doi-asserted-by":"crossref","first-page":"495","DOI":"10.2298\/MPNS0510495Z","volume":"58","author":"M Zivaljevic","year":"2005","unstructured":"Zivaljevic M, Popovic S, Vujkov T (2005) Lambert\u2013Eaton myasthenic syndrome\u2014a rare manifestation of paraneoplastic syndrome in ovarian cancer\u2014case report. Med Pregled 58:495\u2013497","journal-title":"Med Pregled"},{"key":"8541_CR17","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/1752-1947-6-281","volume":"6","author":"H Arai","year":"2012","unstructured":"Arai H, Inui K, Hashimoto K et al (2012) Lung adenocarcinoma with Lambert\u2013Eaton myasthenic syndrome indicated by voltage-gated calcium channel: a case report. J Med Case Rep 6:281","journal-title":"J Med Case Rep"},{"key":"8541_CR18","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1007\/s10072-015-2107-3","volume":"36","author":"F Bombelli","year":"2015","unstructured":"Bombelli F, Lispi L, Calabro F, Corsi FM, Petrucci A (2015) Lambert\u2013Eaton myasthenic syndrome associated to Merkel cell carcinoma: report of a case. Neurol Sci 36:1491\u20131492","journal-title":"Neurol Sci"},{"key":"8541_CR19","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0090-4295(98)00583-4","volume":"54","author":"DR Collins","year":"1999","unstructured":"Collins DR, Connolly S, Burns M et al (1999) Lambert\u2013Eaton myasthenic syndrome in association with transitional cell carcinoma: a previously unrecognized association. Urology 54:162","journal-title":"Urology"},{"key":"8541_CR20","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S0022-5347(05)64091-8","volume":"169","author":"B Delahunt","year":"2003","unstructured":"Delahunt B, Abernethy DA, Johnson CA, Nacey JN (2003) Prostate carcinoma and the Lambert\u2013Eaton myasthenic syndrome. J Urol 169:278\u2013279","journal-title":"J Urol"},{"key":"8541_CR21","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1136\/jnnp.64.6.819","volume":"64","author":"C Galton","year":"1998","unstructured":"Galton C, Thomson D, Boyle R (1998) Lambert\u2013Eaton myasthenic syndrome and non-pulmonary small cell carcinoma. J Neurol Neurosurg Psychiatry 64:819\u2013820","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8541_CR22","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/mus.21032","volume":"37","author":"C Grommes","year":"2008","unstructured":"Grommes C, Preston DC, Al-Kadhimi Z, Alshekhlee A (2008) Lambert\u2013Eaton syndrome with large-cell neuroendocrine carcinoma of the lung. Muscle Nerve 37:786\u2013789","journal-title":"Muscle Nerve"},{"key":"8541_CR23","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/00131402-200003000-00004","volume":"1","author":"B Katirji","year":"2000","unstructured":"Katirji B (2000) Lambert\u2013Eaton myasthenic syndrome: a harbinger to transitional cell carcinoma of the urinary bladder. J Clin Neuromuscul Dis 1:134\u2013136","journal-title":"J Clin Neuromuscul Dis"},{"key":"8541_CR24","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1590\/S1806-37132008000500014","volume":"34","author":"FM Milanez","year":"2008","unstructured":"Milanez FM, Pereira CA, Trindade PH, Milinavicius R, Coletta EN (2008) Lung adenocarcinoma, dermatomyositis, and Lambert\u2013Eaton myasthenic syndrome: a rare combination. J Bras Pneumol 34:333\u2013336","journal-title":"J Bras Pneumol"},{"key":"8541_CR25","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1007\/s10072-015-2315-x","volume":"36","author":"C Monteiro","year":"2015","unstructured":"Monteiro C, Moreira I, Lima JL, Santos E (2015) Lambert\u2013Eaton myasthenic syndrome and prostatic adenocarcinoma. Neurol Sci 36:2145\u20132146","journal-title":"Neurol Sci"},{"key":"8541_CR26","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1002\/mus.24610","volume":"51","author":"M Nalbantoglu","year":"2015","unstructured":"Nalbantoglu M, Kose L, Uzun N et al (2015) Lambert\u2013Eaton myasthenic syndrome associated with thymic neuroendocrine carcinoma. Muscle Nerve 51:936\u2013938","journal-title":"Muscle Nerve"},{"key":"8541_CR27","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s11845-008-0257-5","volume":"180","author":"L Romics Jr","year":"2011","unstructured":"Romics L Jr, McNamara B, Cronin PA et al (2011) Unusual paraneoplastic syndromes of breast carcinoma: a combination of cerebellar degeneration and Lambert\u2013Eaton myasthenic syndrome. Ir J Med Sci 180:569\u2013571","journal-title":"Ir J Med Sci"},{"key":"8541_CR28","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.neurol.2007.08.004","volume":"164","author":"E Shipley","year":"2008","unstructured":"Shipley E, Krim E, Deminiere C, Lagueny A (2008) Lambert\u2013Eaton myasthenic syndrome associated with vocal cord carcinoma. Rev Neurol (Paris) 164:72\u201376","journal-title":"Rev Neurol (Paris)"},{"key":"8541_CR29","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/mus.24934","volume":"53","author":"DB Simmons","year":"2016","unstructured":"Simmons DB, Duginski TM, McClean JC, Amato AA, Sladky JH (2016) Lambert\u2013Eaton myasthenic syndrome and merkel cell carcinoma. Muscle Nerve 53:325\u2013326","journal-title":"Muscle Nerve"},{"key":"8541_CR30","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/mus.880180707","volume":"18","author":"Z Argov","year":"1995","unstructured":"Argov Z, Shapira Y, Averbuch-Heller L, Wirguin I (1995) Lambert\u2013Eaton myasthenic syndrome (LEMS) in association with lymphoproliferative disorders. Muscle Nerve 18:715\u2013719","journal-title":"Muscle Nerve"},{"key":"8541_CR31","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jneuroim.2008.05.025","volume":"201\u2013202","author":"MJ Titulaer","year":"2008","unstructured":"Titulaer MJ, Wirtz PW, Kuks JB et al (2008) The Lambert\u2013Eaton myasthenic syndrome 1988\u20132008: a clinical picture in 97 patients. J Neuroimmunol 201\u2013202:153\u2013158","journal-title":"J Neuroimmunol"},{"key":"8541_CR32","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/JTO.0b013e3181c3f4f1","volume":"5","author":"M Payne","year":"2010","unstructured":"Payne M, Bradbury P, Lang B et al (2010) Prospective study into the incidence of Lambert Eaton myasthenic syndrome in small cell lung cancer. J Thorac Oncol 5:34\u201338","journal-title":"J Thorac Oncol"},{"key":"8541_CR33","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.pediatrneurol.2013.08.009","volume":"50","author":"M Hajjar","year":"2014","unstructured":"Hajjar M, Markowitz J, Darras BT et al (2014) Lambert\u2013Eaton syndrome, an unrecognized treatable pediatric neuromuscular disorder: three patients and literature review. Pediatr Neurol 50:11\u201317","journal-title":"Pediatr Neurol"},{"key":"8541_CR34","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1196\/annals.1405.030","volume":"1132","author":"MJ Titulaer","year":"2008","unstructured":"Titulaer MJ, Verschuuren JJ (2008) Lambert\u2013Eaton myasthenic syndrome: tumor versus nontumor forms. Ann N Y Acad Sci 1132:129\u2013134","journal-title":"Ann N Y Acad Sci"},{"key":"8541_CR35","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1007\/s00415-004-0528-7","volume":"251","author":"PW Wirtz","year":"2004","unstructured":"Wirtz PW, Bradshaw J, Wintzen AR, Verschuuren JJ (2004) Associated autoimmune diseases in patients with the Lambert\u2013Eaton myasthenic syndrome and their families. J Neurol 251:1255\u20131259","journal-title":"J Neurol"},{"key":"8541_CR36","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/rheumatology\/29.1.75-a","volume":"29","author":"P Peris","year":"1990","unstructured":"Peris P, Del Olme J, Gratacos J, Munoz J (1990) The Lambert\u2013Eaton myasthenic syndrome in association with rheumatoid arthritis. Br J Rheumatol 29:75\u201376","journal-title":"Br J Rheumatol"},{"key":"8541_CR37","first-page":"1292","volume":"23","author":"A Deodhar","year":"1996","unstructured":"Deodhar A, Norden J, So Y, Bennett R (1996) The association of systemic lupus erythematosus and Lambert\u2013Eaton myasthenic syndrome. J Rheumatol 23:1292\u20131294","journal-title":"J Rheumatol"},{"key":"8541_CR38","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/WNO.0000000000000258","volume":"36","author":"JD Young","year":"2015","unstructured":"Young JD, Leavitt JA (2015) Lambert\u2013Eaton myasthenic syndrome: ocular signs and symptoms. J Neuroophthalmol 36:20\u201322","journal-title":"J Neuroophthalmol"},{"key":"8541_CR39","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s40120-015-0034-0","volume":"4","author":"R Mantegazza","year":"2015","unstructured":"Mantegazza R, Meisel A, Sieb JP, Masson GL, Desnuelle C, Essing M (2015) The European LEMS Registry: baseline demographics and treatment approaches. Neurol Ther 4:105\u2013124","journal-title":"Neurol Ther"},{"key":"8541_CR40","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(05)76153-5","volume":"353","author":"P Maddison","year":"1999","unstructured":"Maddison P, Newsom-Davis J, Mills KR, Souhami RL (1999) Favourable prognosis in Lambert\u2013Eaton myasthenic syndrome and small-cell lung carcinoma. Lancet 353:117\u2013118","journal-title":"Lancet"},{"key":"8541_CR41","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1097\/JTO.0b013e3181e15d74","volume":"5","author":"P Maddison","year":"2010","unstructured":"Maddison P, Silcocks P (2010) Prospective study of Lambert\u2013Eaton myasthenic syndrome in small cell lung cancer. J Thorac Oncol 5:1309\u20131310","journal-title":"J Thorac Oncol"},{"key":"8541_CR42","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jneuroim.2005.04.001","volume":"164","author":"PW Wirtz","year":"2005","unstructured":"Wirtz PW, Lang B, Graus F et al (2005) P\/Q-type calcium channel antibodies, Lambert\u2013Eaton myasthenic syndrome and survival in small cell lung cancer. J Neuroimmunol 164:161\u2013165","journal-title":"J Neuroimmunol"},{"issue":"Suppl 1","key":"8541_CR43","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1038\/sj.bjp.0706442","volume":"147","author":"AC Dolphin","year":"2006","unstructured":"Dolphin AC (2006) A short history of voltage-gated calcium channels. Br J Pharmacol 147(Suppl 1):S56\u2013S62","journal-title":"Br J Pharmacol"},{"key":"8541_CR44","first-page":"S21","volume":"5","author":"VA Lennon","year":"1982","unstructured":"Lennon VA, Lambert EH, Whittingham S, Fairbanks V (1982) Autoimmunity in the Lambert\u2013Eaton myasthenic syndrome. Muscle Nerve 5:S21\u2013S25","journal-title":"Muscle Nerve"},{"key":"8541_CR45","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1056\/NEJM199506013322203","volume":"332","author":"VA Lennon","year":"1995","unstructured":"Lennon VA, Kryzer TJ, Griesmann GE et al (1995) Calcium-channel antibodies in the Lambert\u2013Eaton syndrome and other paraneoplastic syndromes. N Engl J Med 332:1467\u20131474","journal-title":"N Engl J Med"},{"key":"8541_CR46","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/mus.24295","volume":"51","author":"RK Hajela","year":"2015","unstructured":"Hajela RK, Huntoon KM, Atchison WD (2015) Lambert\u2013Eaton syndrome antibodies target multiple subunits of voltage-gated Ca2+ channels. Muscle Nerve 51:176\u2013184","journal-title":"Muscle Nerve"},{"key":"8541_CR47","doi-asserted-by":"crossref","first-page":"7636","DOI":"10.1073\/pnas.80.24.7636","volume":"80","author":"H Fukunaga","year":"1983","unstructured":"Fukunaga H, Engel AG, Lang B, Newsom-Davis J, Vincent A (1983) Passive transfer of Lambert\u2013Eaton myasthenic syndrome with IgG from man to mouse depletes the presynaptic membrane active zones. Proc Natl Acad Sci USA 80:7636\u20137640","journal-title":"Proc Natl Acad Sci USA"},{"key":"8541_CR48","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/317737a0","volume":"317","author":"A Roberts","year":"1985","unstructured":"Roberts A, Perera S, Lang B, Vincent A, Newsom-Davis J (1985) Paraneoplastic myasthenic syndrome IgG inhibits 45Ca2+ flux in a human small cell carcinoma line. Nature 317:737\u2013739","journal-title":"Nature"},{"key":"8541_CR49","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0165-5728(00)00431-8","volume":"113","author":"M Benatar","year":"2001","unstructured":"Benatar M, Blaes F, Johnston I et al (2001) Presynaptic neuronal antigens expressed by a small cell lung carcinoma cell line. J Neuroimmunol 113:153\u2013162","journal-title":"J Neuroimmunol"},{"key":"8541_CR50","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S0140-6736(89)90893-3","volume":"2","author":"E Sher","year":"1989","unstructured":"Sher E, Gotti C, Canal N et al (1989) Specificity of calcium channel autoantibodies in Lambert\u2013Eaton myasthenic syndrome. Lancet 2:640\u2013643","journal-title":"Lancet"},{"key":"8541_CR51","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1749-6632.1989.tb24104.x","volume":"560","author":"DW Wray","year":"1989","unstructured":"Wray DW, Lang B, Newsom-Davis J, Peers C (1989) Antibodies against calcium channels in the Lambert\u2013Eaton myasthenic syndrome. Ann N Y Acad Sci 560:269\u2013277","journal-title":"Ann N Y Acad Sci"},{"key":"8541_CR52","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0198-8859(01)00270-1","volume":"62","author":"PW Wirtz","year":"2001","unstructured":"Wirtz PW, Roep BO, Schreuder GM et al (2001) HLA class I and II in Lambert\u2013Eaton myasthenic syndrome without associated tumor. Hum Immunol 62:809\u2013813","journal-title":"Hum Immunol"},{"key":"8541_CR53","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/ana.410220203","volume":"22","author":"T Fukuoka","year":"1987","unstructured":"Fukuoka T, Engel AG, Lang B et al (1987) Lambert\u2013Eaton myasthenic syndrome: I. Early morphological effects of IgG on the presynaptic membrane active zones. Ann Neurol 22:193\u2013199","journal-title":"Ann Neurol"},{"key":"8541_CR54","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1212\/WNL.32.9.1061","volume":"32","author":"PC Molenaar","year":"1982","unstructured":"Molenaar PC, Newsom-Davis J, Polak RL, Vincent A (1982) Eaton\u2013Lambert syndrome: acetylcholine and choline acetyltransferase in skeletal muscle. Neurology 32:1061\u20131065","journal-title":"Neurology"},{"key":"8541_CR55","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/nature03112","volume":"432","author":"H Nishimune","year":"2004","unstructured":"Nishimune H, Sanes JR, Carlson SS (2004) A synaptic laminin-calcium channel interaction organizes active zones in motor nerve terminals. Nature 432:580\u2013587","journal-title":"Nature"},{"key":"8541_CR56","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1523\/JNEUROSCI.3771-10.2011","volume":"31","author":"J Chen","year":"2011","unstructured":"Chen J, Billings SE, Nishimune H (2011) Calcium channels link the muscle-derived synapse organizer laminin beta2 to Bassoon and CAST\/Erc2 to organize presynaptic active zones. J Neurosci 31:512\u2013525","journal-title":"J Neurosci"},{"key":"8541_CR57","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/ana.410420204","volume":"42","author":"SA Waterman","year":"1997","unstructured":"Waterman SA, Lang B, Newsom-Davis J (1997) Effect of Lambert\u2013Eaton myasthenic syndrome antibodies on autonomic neurons in the mouse. Ann Neurol 42:147\u2013156","journal-title":"Ann Neurol"},{"key":"8541_CR58","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1212\/01.WNL.0000037485.56217.5F","volume":"59","author":"YK Nakao","year":"2002","unstructured":"Nakao YK, Motomura M, Fukudome T et al (2002) Seronegative Lambert\u2013Eaton myasthenic syndrome: study of 110 Japanese patients. Neurology 59:1773\u20131775","journal-title":"Neurology"},{"key":"8541_CR59","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/mus.20672","volume":"35","author":"SJ Oh","year":"2007","unstructured":"Oh SJ, Hatanaka Y, Claussen GC, Sher E (2007) Electrophysiological differences in seropositive and seronegative Lambert\u2013Eaton myasthenic syndrome. Muscle Nerve 35:178\u2013183","journal-title":"Muscle Nerve"},{"key":"8541_CR60","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jneuroim.2008.04.040","volume":"201\u2013202","author":"M Takamori","year":"2008","unstructured":"Takamori M (2008) Lambert\u2013Eaton myasthenic syndrome: search for alternative autoimmune targets and possible compensatory mechanisms based on presynaptic calcium homeostasis. J Neuroimmunol 201\u2013202:145\u2013152","journal-title":"J Neuroimmunol"},{"key":"8541_CR61","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0022-510X(95)00162-U","volume":"133","author":"M Takamori","year":"1995","unstructured":"Takamori M, Takahashi M, Yasukawa Y et al (1995) Antibodies to recombinant synaptotagmin and calcium channel subtypes in Lambert\u2013Eaton myasthenic syndrome. J Neurol Sci 133:95\u2013101","journal-title":"J Neurol Sci"},{"key":"8541_CR62","doi-asserted-by":"crossref","first-page":"4260","DOI":"10.1200\/JCO.2008.20.6169","volume":"27","author":"MJ Titulaer","year":"2009","unstructured":"Titulaer MJ, Klooster R, Potman M et al (2009) SOX antibodies in small-cell lung cancer and Lambert\u2013Eaton myasthenic syndrome: frequency and relation with survival. J Clin Oncol 27:4260\u20134267","journal-title":"J Clin Oncol"},{"key":"8541_CR63","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1212\/01.wnl.0000281663.81079.24","volume":"70","author":"L Sabater","year":"2008","unstructured":"Sabater L, Titulaer M, Saiz A et al (2008) SOX1 antibodies are markers of paraneoplastic Lambert\u2013Eaton myasthenic syndrome. Neurology 70:924\u2013928","journal-title":"Neurology"},{"key":"8541_CR64","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1212\/WNL.59.7.1085","volume":"59","author":"Z Odabasi","year":"2002","unstructured":"Odabasi Z, Demirci M, Kim DS et al (2002) Postexercise facilitation of reflexes is not common in Lambert\u2013aton myasthenic syndrome. Neurology 59:1085\u20131087","journal-title":"Neurology"},{"key":"8541_CR65","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.jclinane.2014.09.009","volume":"26","author":"TN Weingarten","year":"2014","unstructured":"Weingarten TN, Araka CN, Mogensen ME et al (2014) Lambert\u2013Eaton myasthenic syndrome during anesthesia: a report of 37 patients. J Clin Anesth 26:648\u2013653","journal-title":"J Clin Anesth"},{"key":"8541_CR66","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/mus.20389","volume":"32","author":"SJ Oh","year":"2005","unstructured":"Oh SJ, Kurokawa K, Claussen GC, Ryan HF Jr (2005) Electrophysiological diagnostic criteria of Lambert\u2013Eaton myasthenic syndrome. Muscle Nerve 32:515\u2013520","journal-title":"Muscle Nerve"},{"key":"8541_CR67","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/mus.1139","volume":"24","author":"Medicine AQACAAoE","year":"2001","unstructured":"Medicine AQACAAoE (2001) Practice parameter for repetitive nerve stimulation and single fiber EMG evaluation of adults with suspected myasthenia gravis or Lambert\u2013Eaton myasthenic syndrome: summary statement. Muscle Nerve 24:1236\u20131238","journal-title":"Muscle Nerve"},{"key":"8541_CR68","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/mus.23638","volume":"47","author":"SJ Oh","year":"2013","unstructured":"Oh SJ, Ohira M (2013) Single-fiber EMG and clinical correlation in Lambert\u2013Eaton myasthenic syndrome. Muscle Nerve 47:664\u2013667","journal-title":"Muscle Nerve"},{"key":"8541_CR69","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/ana.410290313","volume":"29","author":"K Leys","year":"1991","unstructured":"Leys K, Lang B, Johnston I, Newsom-Davis J (1991) Calcium channel autoantibodies in the Lambert\u2013Eaton myasthenic syndrome. Ann Neurol 29:307\u2013314","journal-title":"Ann Neurol"},{"key":"8541_CR70","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jneuroim.2008.08.002","volume":"204","author":"HL Pellkofer","year":"2008","unstructured":"Pellkofer HL, Armbruster L, Krumbholz M et al (2008) Lambert\u2013Eaton myasthenic syndrome differential reactivity of tumor versus non-tumor patients to subunits of the voltage-gated calcium channel. J Neuroimmunol 204:136\u2013139","journal-title":"J Neuroimmunol"},{"key":"8541_CR71","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1600-0404.2011.01572.x","volume":"125","author":"O Stich","year":"2012","unstructured":"Stich O, Klages E, Bischler P et al (2012) SOX1 antibodies in sera from patients with paraneoplastic neurological syndromes. Acta Neurol Scand 125:326\u2013331","journal-title":"Acta Neurol Scand"},{"key":"8541_CR72","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jneuroim.2010.07.005","volume":"226","author":"M Tschernatsch","year":"2010","unstructured":"Tschernatsch M, Singh P, Gross O et al (2010) Anti-SOX1 antibodies in patients with paraneoplastic and non-paraneoplastic neuropathy. J Neuroimmunol 226:177\u2013180","journal-title":"J Neuroimmunol"},{"key":"8541_CR73","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1212\/WNL.37.8.1411","volume":"37","author":"SJ Oh","year":"1987","unstructured":"Oh SJ, Dwyer DS, Bradley RJ (1987) Overlap myasthenic syndrome: combined myasthenia gravis and Eaton\u2013Lamert syndrome. Neurology 37:1411\u20131414","journal-title":"Neurology"},{"key":"8541_CR74","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1136\/jnnp.54.5.452","volume":"54","author":"J Newsom-Davis","year":"1991","unstructured":"Newsom-Davis J, Leys K, Vinvent A et al (1991) Immunological evidence for the co-existence of the Lambert\u2013Eaton myasthenic syndrome and myasthenia gravis in two patients. J Neurol Neurosurg Psychiatry 54:452\u2013453","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8541_CR75","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1016\/j.clinph.2014.06.031","volume":"125","author":"R Hulsbrink","year":"2014","unstructured":"Hulsbrink R, Hashemolhosseini S (2014) Lambert\u2013Eaton myasthenic syndrome\u2014diagnosis, pathogenesis and therapy. Clin Neurophysiol 125:2328\u20132336","journal-title":"Clin Neurophysiol"},{"key":"8541_CR76","doi-asserted-by":"crossref","first-page":"4276","DOI":"10.1200\/JCO.2008.17.5133","volume":"26","author":"MJ Titulaer","year":"2008","unstructured":"Titulaer MJ, Wirtz PW, Willems LN et al (2008) Screening for small-cell lung cancer: a follow-up study of patients with Lambert\u2013Eaton myasthenic syndrome. J Clin Oncol 26:4276\u20134281","journal-title":"J Clin Oncol"},{"key":"8541_CR77","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1468-1331.2010.03220.x","volume":"18","author":"MJ Titulaer","year":"2011","unstructured":"Titulaer MJ, Soffietti R, Dalmau J et al (2011) Screening for tumors in paraneoplastic syndromes: report of an EFNS task force. Eur J Neurol 18:19 (e13)","journal-title":"Eur J Neurol"},{"key":"8541_CR78","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1517\/14656566.7.10.1323","volume":"7","author":"JJG Verschuuren","year":"2006","unstructured":"Verschuuren JJG, Wirtz PW, Titulaer MJ et al (2006) Available treatment options for the management of Lambert\u2013Eaton myasthenic syndrome. Opin Pharmacother 7:1323\u20131336","journal-title":"Opin Pharmacother"},{"key":"8541_CR79","doi-asserted-by":"crossref","first-page":"36453","DOI":"10.1074\/jbc.M109.075523","volume":"284","author":"ZZ Wu","year":"2009","unstructured":"Wu ZZ, Li DP, Chen SR, Pan HL (2009) Aminopyridines potentiate synaptic and neuromuscular transmission by targeting the voltage-activated calcium channel beta subunit. J Biol Chem 284:36453\u201336461","journal-title":"J Biol Chem"},{"key":"8541_CR80","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1586\/eci.10.57","volume":"6","author":"PW Wirtz","year":"2010","unstructured":"Wirtz PW, Titulaer MJ, Gerven JM, Verschuuren JJ (2010) 3,4-diaminopyridine for the treatment of Lambert\u2013Eaton myasthenic syndrome. Expert Rev Clin Immunol 6:867\u2013874","journal-title":"Expert Rev Clin Immunol"},{"key":"8541_CR81","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003279.pub3","author":"M Keogh","year":"2011","unstructured":"Keogh M, Sedehizadeh S, Maddison P (2011) Treatment for Lambert\u2013Eaton myasthenic syndrome. Cochrane Database Syst Rev CD003279 \u00a0doi: 10.1002\/14651858.CD003279.pub3","journal-title":"Cochrane Database Syst Rev"},{"issue":"Suppl 1","key":"8541_CR82","doi-asserted-by":"crossref","first-page":"I14","DOI":"10.1007\/s00415-005-1104-5","volume":"252","author":"I Illa","year":"2005","unstructured":"Illa I (2005) IVIg in myasthenia gravis, Lambert Eaton mysasthenic syndrome and inflammatory myopathies: current status. J Neurol 252(Suppl 1):I14\u2013I18","journal-title":"J Neurol"},{"key":"8541_CR83","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1212\/WNL.47.3.678","volume":"47","author":"PG Bain","year":"1996","unstructured":"Bain PG, Motomura M, Newsom-Davis J et al (1996) Effects of intravenous immunoglobulin on muscle weakness and calcium-channel autoantibodies in the Lambert\u2013Eaton myasthenic syndrome. Neurology 47:678\u2013683","journal-title":"Neurology"},{"key":"8541_CR84","first-page":"1066","volume":"63","author":"HC Lehmann","year":"2006","unstructured":"Lehmann HC, Hartung HP, Hetzel GR et al (2006) Plasma exchange in neuroimmunological disorders: part 2. Treatment of neuromuscular disorders. Arch Neurol 63:1066\u20131071","journal-title":"Treatment of neuromuscular disorders. Arch Neurol"}],"updated-by":[{"DOI":"10.1007\/s00415-017-8556-2","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2017,7,10]],"date-time":"2017-07-10T00:00:00Z","timestamp":1499644800000}}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-017-8541-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-017-8541-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-017-8541-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,10]],"date-time":"2020-10-10T01:48:43Z","timestamp":1602294523000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-017-8541-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,12]]},"references-count":84,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["8541"],"URL":"https:\/\/doi.org\/10.1007\/s00415-017-8541-9","relation":{"erratum":[{"id-type":"doi","id":"10.1007\/s00415-017-8556-2","asserted-by":"object"}]},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,12]]}}}